Total Payments
$2,745
2024 Payments
$285.56
Companies
30
Transactions
161
Medicare Patients
6,807
Medicare Billing
$381,770
Payment Breakdown by Category
Food & Beverage$2,745 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,745 | 161 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AbbVie Inc. | $433.16 | 28 | $0 (2023) |
| Amgen Inc. | $377.66 | 19 | $0 (2024) |
| Novo Nordisk Inc | $321.00 | 21 | $0 (2024) |
| PFIZER INC. | $223.32 | 7 | $0 (2019) |
| Merck Sharp & Dohme Corporation | $181.37 | 14 | $0 (2021) |
| Lilly USA, LLC | $164.86 | 11 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $121.37 | 9 | $0 (2023) |
| Amarin Pharma Inc. | $98.39 | 4 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $94.76 | 5 | $0 (2023) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $89.64 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $285.56 | 16 | Lilly USA, LLC ($78.30) |
| 2023 | $450.57 | 25 | Novo Nordisk Inc ($77.14) |
| 2022 | $370.92 | 23 | ABBVIE INC. ($92.83) |
| 2021 | $796.44 | 52 | AbbVie Inc. ($273.12) |
| 2020 | $291.99 | 21 | Amgen Inc. ($63.62) |
| 2019 | $525.80 | 22 | PFIZER INC. ($223.32) |
| 2018 | $11.70 | 1 | Merck Sharp & Dohme Corporation ($11.70) |
| 2017 | $12.17 | 1 | Purdue Pharma L.P. ($12.17) |
All Payment Transactions
161 individual payment records from CMS Open Payments — Page 1 of 7
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/21/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.48 | General |
| Category: Biological | ||||||
| 10/03/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $23.90 | General |
| Category: NEUROLOGY | ||||||
| 09/16/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.16 | General |
| Category: Respiratory | ||||||
| 09/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $15.89 | General |
| 09/03/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: UROLOGY | ||||||
| 08/13/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Obesity | ||||||
| 06/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: Diabetes | ||||||
| 05/17/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Diabetes | ||||||
| 05/08/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $14.89 | General |
| Category: GASTROENTEROLOGY | ||||||
| 03/21/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.94 | General |
| Category: Diabetes | ||||||
| 03/19/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.00 | General |
| Category: Diabetes | ||||||
| 02/27/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Obesity | ||||||
| 02/08/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Inflammation | ||||||
| 02/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 01/29/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Oncology | ||||||
| 12/14/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $16.77 | General |
| Category: Diabetes | ||||||
| 12/05/2023 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $14.07 | General |
| Category: Bone Health | ||||||
| 11/27/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Inflammation | ||||||
| 10/26/2023 | Shield Therapeutics Inc | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Hematology | ||||||
| 09/28/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $22.54 | General |
| Category: Inflammation | ||||||
| 09/17/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 09/13/2023 | GlaxoSmithKline, LLC. | AREXVY (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: RESPIRATORY | ||||||
| 09/07/2023 | Ethicon US, LLC | Enseal (Device) | Food and Beverage | In-kind items and services | $58.03 | General |
| Category: Energy | ||||||
| 08/10/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $20.00 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,644 | 2,518 | $265,760 | $103,306 |
| 2022 | 28 | 1,607 | 2,394 | $243,502 | $90,140 |
| 2021 | 34 | 1,910 | 2,786 | $277,068 | $105,958 |
| 2020 | 33 | 1,646 | 2,654 | $260,994 | $82,366 |
Total Patients
6,807
Total Services
10,352
Medicare Billing
$381,770
Procedure Codes
123
All Medicare Procedures & Services
123 procedure records from CMS Medicare Utilization — Page 2 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 11 | 14 | $728.00 | $153.02 | 21.0% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 20 | 20 | $300.00 | $122.20 | 40.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 25 | 35 | $770.00 | $108.85 | 14.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 127 | 244 | $58,560 | $20,124 | 34.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 126 | 263 | $39,450 | $15,099 | 38.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 116 | 116 | $17,980 | $14,660 | 81.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 67 | 68 | $4,760 | $4,654 | 97.8% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 31 | 32 | $12,800 | $4,652 | 36.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 14 | 14 | $5,110 | $3,888 | 76.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 23 | 46 | $9,430 | $3,513 | 37.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 137 | 196 | $14,700 | $2,580 | 17.5% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 146 | 246 | $17,220 | $2,557 | 14.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 25 | 42 | $6,300 | $2,157 | 34.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 68 | 69 | $2,070 | $1,959 | 94.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 143 | 230 | $5,750 | $1,758 | 30.6% |
| 77067 | Screening mammography | Office | 2022 | 19 | 19 | $5,700 | $1,706 | 29.9% |
| 82306 | Vitamin d-3 level | Office | 2022 | 40 | 48 | $3,936 | $1,381 | 35.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 17 | 40 | $2,600 | $1,164 | 44.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 20 | 20 | $3,000 | $1,096 | 36.5% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 46 | 65 | $3,380 | $1,077 | 31.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 146 | 258 | $2,580 | $764.43 | 29.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 53 | 78 | $2,730 | $747.50 | 27.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2022 | 20 | 20 | $6,600 | $717.27 | 10.9% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 20 | 22 | $3,520 | $670.76 | 19.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2022 | 34 | 34 | $1,870 | $648.20 | 34.7% |
About Dr. Joshua Splinter, MD
Dr. Joshua Splinter, MD is a Family Medicine healthcare provider based in Athens, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2012. The National Provider Identifier (NPI) number assigned to this provider is 1306109228.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joshua Splinter, MD has received a total of $2,745 in payments from pharmaceutical and medical device companies, with $285.56 received in 2024. These payments were reported across 161 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($2,745).
As a Medicare-enrolled provider, Splinter has provided services to 6,807 Medicare beneficiaries, totaling 10,352 services with total Medicare billing of $381,770. Data is available for 4 years (2020–2023), covering 123 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Other Specialties Family Medicine, Internal Medicine
- Location Athens, TX
- Active Since 06/18/2012
- Last Updated 11/16/2018
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1306109228
Products in Payments
- LINZESS (Drug) $215.48
- EVENITY (Biological) $207.24
- EUCRISA (Drug) $189.85
- JANUVIA (Drug) $127.19
- Ozempic (Drug) $117.53
- MOUNJARO (Drug) $109.87
- Vascepa (Drug) $98.39
- Rybelsus (Drug) $97.14
- XIFAXAN (Drug) $89.64
- UBRELVY (Drug) $87.50
- REXULTI (Drug) $80.28
- Prolia (Biological) $73.23
- XARELTO (Drug) $72.91
- VRAYLAR (Drug) $63.03
- Otezla (Drug) $62.05
- Enseal (Device) $58.03
- Yupelri (Drug) $54.71
- BELSOMRA (Drug) $54.18
- JARDIANCE (Drug) $53.61
- Saxenda (Drug) $51.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Athens
Farris Johnson, Md, MD
Family Medicine — Payments: $30,847
Family Medicine $30,847
Timothy Law, Do, DO
Family Medicine — Payments: $18,254
Family Medicine $18,254
Dr. Henry Morris, M.d, M.D
Family Medicine — Payments: $16,624
Family Medicine $16,624
Alvin Wilson, D.o, D.O
Family Medicine — Payments: $13,833
Family Medicine $13,833
Dr. James Shiver, M.d, M.D
Family Medicine — Payments: $13,306
Family Medicine $13,306
Dr. Paul Haver, M.d, M.D
Family Medicine — Payments: $11,681
Family Medicine $11,681